{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:04:35Z","timestamp":1776704675092,"version":"3.51.2"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T00:00:00Z","timestamp":1413244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijid.2014.08.018","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T11:59:50Z","timestamp":1414151990000},"page":"91-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae"],"prefix":"10.1016","volume":"29","author":[{"given":"Takanori","family":"Asakura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2014.08.018_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2014.08.018_bib0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2014.08.018_bib0015","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkl035","article-title":"Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases","volume":"57","author":"Calbo","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2014.08.018_bib0020","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijid.2012.09.010","article-title":"The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae","volume":"17","author":"Doi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2014.08.018_bib0025","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1001\/jama.2008.896","article-title":"Carbapenem-resistant Enterobacteriaceae: a potential threat","volume":"300","author":"Schwaber","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2014.08.018_bib0030","first-page":"165","article-title":"Vital signs: carbapenem-resistant, Enterobacteriaceae","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2014.08.018_bib0035","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/666642","article-title":"Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship","volume":"33","author":"Marchaim","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2014.08.018_bib0040","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1185\/03007995.2012.748653","article-title":"Efficacy and safety of ceftazidime\u2013avibactam versus imipenem\u2013cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study","volume":"28","author":"Vazquez","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijid.2014.08.018_bib0045","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.amjmed.2003.07.005","article-title":"Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis","volume":"115","author":"Harbarth","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.ijid.2014.08.018_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-150-1-200901060-00005","article-title":"Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia","volume":"150","author":"Venditti","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2014.08.018_bib0055","series-title":"Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. M100-S21","year":"2011"},{"key":"10.1016\/j.ijid.2014.08.018_bib0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijid.2014.08.018_bib0065","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","article-title":"American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in, sepsis","volume":"20","year":"1992","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2014.08.018_bib0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jinf.2010.10.009","article-title":"Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis","volume":"62","author":"Lee","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2014.08.018_bib0075","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1086\/340616","article-title":"Nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization","volume":"34","author":"Blot","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2014.08.018_bib0080","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archinte.165.12.1375","article-title":"Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: variability by site of infection","volume":"165","author":"Hyle","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijid.2014.08.018_bib0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhin.2007.11.012","article-title":"Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality","volume":"68","author":"Pe\u00f1a","year":"2008","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2014.08.018_bib0090","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2014.08.018_bib0095","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2014.08.018_bib0100","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy","volume":"48","author":"Kang","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214016361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214016361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T07:56:19Z","timestamp":1538121379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214016361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":20,"alternative-id":["S1201971214016361"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2014.08.018","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2014.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}